(E) -Aztreonam

• Description:

  (E) -Aztreonam (SQ-28429) is a monocyclic beta-lactam antibiotic. (E) -Aztreonam has the potential for the research of infections caused by gram-negative pathogens[1][2][3].

• Product Name Alternative:

  SQ-28429

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H312, H332

• Target:

  Antibiotic; Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/e-aztreonam.html

• Purity:

  98.68

• Solubility:

  DMSO : 100 mg/mL

• Smiles:

  CC(C)(O/N=C(C1=CSC(N)=N1)/C(N[C@H]2[C@H](C)N(S(=O)(O)=O)C2=O)=O)C(O)=O

• Molecular Formula:

  C13H17N5O8S2

• Molecular Weight:

  435.43

• Precautions:

  H302, H312, H332

• References & Citations:

  [1]Neu HC. Aztreonam activity, pharmacology, and clinical uses. Am J Med. 1990 Mar 23;88 (3C) :2S-6S; discussion 38S-42S.|[2]Childs, S. J., et al. Aztreonam. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1986, 6 (4), 138-149.|[3]Ortega E, et al. Effects of aztreonam on natural immunity in mice. Int J Antimicrob Agents. 1999 Sep;13 (1) :41-6.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [99341-02-3]